The Net Margin of Biofermin Pharmaceutical Co Ltd (4517.T) is 14.32%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2021-03-31 | 14.32% |
| 2020-03-31 | 18.79% |
| 2019-03-31 | 19.97% |
| 2018-03-31 | 20.33% |
| 2017-03-31 | 17.89% |
| 2016-03-31 | 16.45% |
| 2015-03-31 | 20.98% |
| 2014-03-31 | 20.53% |
| 2013-03-31 | 20.62% |
| 2012-03-31 | 18.45% |